Belite Bio News

Maxim Group Maintains Belite Bio(BLTE.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsSep 12 08:32 ET

Belite Bio Analyst Ratings

BenzingaSep 12 06:47 ET

H.C. Wainwright Maintains Belite Bio(BLTE.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsSep 12 06:31 ET

Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Belite Bio, Inc. ADR (BLTE) and Protagonist Therapeutics (PTGX)

TipRanksSep 12 06:25 ET

Maxim Group Maintains Belite Bio(BLTE.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsSep 11 10:32 ET

Maxim Group Maintains Belite Bio(BLTE.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsAug 14 16:31 ET

Belite Bio, Inc.: Strong Buy Rating on Robust Financials and Promising Clinical Trials

TipRanksAug 14 15:47 ET

HC Wainwright & Co. Maintains Buy on Belite Bio, Raises Price Target to $60

BenzingaAug 13 14:15 ET

Belite Bio Analyst Ratings

BenzingaAug 13 10:45 ET

Leerink Partners Maintains Belite Bio(BLTE.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsAug 13 10:32 ET

Benchmark Co. Maintains Belite Bio(BLTE.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsAug 13 08:31 ET

Belite Bio, Inc. ADR (BLTE) Receives a Buy From Benchmark Co.

TipRanksAug 13 07:39 ET

Buy Rating Affirmed for Belite Bio Amidst Promising Developments for Tinlarebant

TipRanksAug 13 06:35 ET

H.C. Wainwright Maintains Belite Bio(BLTE.US) With Buy Rating, Raises Target Price to $60

Moomoo NewsAug 13 06:31 ET

Belite Bio Analyst Ratings

BenzingaJun 20 13:29 ET

Belite Bio Analyst Ratings

BenzingaJun 13 06:28 ET

Buy Rating Affirmed for Belite Bio, Inc. on Strong Clinical Trials and Solid Financial Footing

TipRanksMay 16 12:35 ET

Analysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), CareCloud (CCLD)

TipRanksMay 16 07:06 ET

Buy Rating Affirmed for Belite Bio, Inc. ADR on Strong Financials and Promising Stargardt Disease Drug Prospects

TipRanksMay 16 04:15 ET

HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $59 Price Target

BenzingaMay 15 11:26 ET